Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Simponi Aria

Golimumab

Open in the dashboard

Part D claims

3,813

Prescriptions dispensed, refills included

Drug cost

$28,066,448

Paid at the pharmacy, in all

Prescribers

149

With 11 or more claims of it

In 2024, Medicare Part D recorded 3,813 claims for Simponi Aria (golimumab) from 149 prescribers, at a total drug cost of $28.1 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 23 states and territories
Part D claims for Simponi Aria by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
FL 33 897 $6,662,067
CA 22 611 $4,084,071
TX 19 518 $3,927,852
NJ 12 508 $3,554,242
OK 14 297 $2,265,978
NY 10 184 $1,273,929
AR 4 118 $901,980
AL 3 87 $735,615
TN 4 83 $583,219
AZ 4 75 $595,720
MS 4 72 $604,067
LA 3 60 $419,739
PA 4 55 $433,552
MD 2 51 $522,470
GA 3 44 $331,331
The other 8 states and territories
State Prescribers Claims Drug cost
UT 1 32 $229,767
MO 1 30 $242,114
NC 1 28 $198,965
OH 1 14 $115,847
ME 1 13 $100,565
WV 1 12 $67,867
OR 1 12 $101,508
CT 1 12 $113,981

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 8 of 8
Part D claims for Simponi Aria by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 114 3,073 $22,447,971
Nurse Practitioner 11 242 $1,985,035
Physician Assistant 11 232 $1,735,511
Internal Medicine 9 213 $1,474,674
Hospitalist 1 15 $142,398
Hematology-Oncology 1 15 $86,993
Gastroenterology 1 12 $118,056
Allergy/ Immunology 1 11 $75,809

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Richard Haddad Rheumatology NJ 216 $1,469,428 $11,244
Swati Shah Rheumatology FL 112 $794,817 None on record
Gerald Ho Rheumatology CA 101 $614,665 None on record
Eric Panahi Internal Medicine CA 81 $535,522 $30
Edward Allegra Rheumatology NJ 77 $510,920 $297

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for golimumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record